Vanguard Advisers Inc’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.45K Sell
4
-8
-67% -$2.74K ﹤0.01% 565
2026
Q1
$4.22K Buy
+12
New +$4.28K ﹤0.01% 452

Other funds holding AMGN

Vanguard Advisers Inc's AMGN Position: Q2 2026 in Review

Vanguard Advisers Inc reduced its Amgen (AMGN) stake by 67% in Q2 2026, selling an estimated $2.74K and leaving 4 shares worth $1.45K. The position accounts for ﹤0.01% of the portfolio, ranked #565.

Vanguard Advisers Inc first reported a position in AMGN in Q1 2026 and has held it in 2 quarters since. The position peaked at $4.22K in Q1 2026. 3,137 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Vanguard Advisers Inc held 4 shares of Amgen worth $1.45K as of Q2 2026.
  • Vanguard Advisers Inc sold 8 Amgen shares in Q2 2026, an estimated $2.74K.
  • Amgen made up ﹤0.01% of Vanguard Advisers Inc's portfolio in Q2 2026, its #565 holding.
  • Vanguard Advisers Inc first reported a position in Amgen in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Advisers Inc's Amgen position peaked at $4.22K in Q1 2026.
  • 3,137 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Vanguard Advisers Inc's 13F filing for Q2 2026, filed 13 Aug 2026.